Braskem (BAK) Cash & Equivalents (2016 - 2025)
Braskem has reported Cash & Equivalents over the past 17 years, most recently at $1.9 billion for Q4 2025.
- For Q4 2025, Cash & Equivalents fell 24.47% year-over-year to $1.9 billion; the TTM value through Dec 2025 reached $1.9 billion, down 24.47%, while the annual FY2025 figure was $1.9 billion, 24.47% down from the prior year.
- Cash & Equivalents for Q4 2025 was $1.9 billion at Braskem, up from $1.9 billion in the prior quarter.
- Over five years, Cash & Equivalents peaked at $2.9 billion in Q4 2023 and troughed at $1.6 billion in Q4 2021.
- A 5-year average of $2.3 billion and a median of $2.4 billion in 2022 define the central range for Cash & Equivalents.
- Biggest five-year swings in Cash & Equivalents: crashed 39.39% in 2021 and later surged 52.26% in 2022.
- Year by year, Cash & Equivalents stood at $1.6 billion in 2021, then surged by 52.26% to $2.4 billion in 2022, then grew by 20.94% to $2.9 billion in 2023, then fell by 10.02% to $2.6 billion in 2024, then dropped by 24.47% to $1.9 billion in 2025.
- Business Quant data shows Cash & Equivalents for BAK at $1.9 billion in Q4 2025, $1.9 billion in Q1 2025, and $2.6 billion in Q4 2024.